Fig 5. Effect of maternal Di-(2-ethylhexyl)-phthalate (DEHP) and verapamil exposure from E6.5 to E14.5 on fetal heart Nkx2.5/Gata4/Tbx5/Mef2c/Chf1 protein expression at E15.5.

Differences among different groups were determined by ANOVA followed by a Student–Newman–Keuls multiple comparisons. N = 10, 15, 20 and 10 for vehicle, 500mg/Kg DEHP, 500mg/Kg DEHP & 3mg/Kg verapamil and 3mg/Kg verapamil group, respectively. Data were expressed as Means±SEM. *P<0.05, **P<0.01, ***P<0.001 in comparison with the verapamil group and the vehicle group.